Jacques J. Gorlin has been a consulting economist since October, 1982. He is a recognized expert on the nexus between intellectual property and trade policy and has been a consultant to the research-based pharmaceutical industry for twenty years. As a member of IFAC 3, the predecessor industry advisory group to ITAC 15, Mr. Gorlin closely monitored the 1992 Rio negotiations that established the Convention of Biological Diversity (CBD) and provided industry views to U.S. negotiators on the intellectual property-related provisions of that treaty. Since, he has provided ongoing advice to the pharmaceutical industry on CBD-related issues, including an analysis of the implications for the pharmaceutical industry of U.S. membership in the CBD. Mr. Gorlin received an A.B. in history from Columbia College (1965), an M.A. from the Johns Hopkins School of Advanced International Studies (1967) and his Ph.D. from the Johns Hopkins University (1971).